about
Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma.Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer ModelsISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cellsCorrigendum to "Combination Therapy with EpCAM-CAR-NK-92 Cells and Regorafenib against Human Colorectal Cancer Models"Functional roles of circular RNAs during epithelial-to-mesenchymal transitionH1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinomaThe optimization system for preparation of TG1 competent cells and electrotransformation
P50
Q48504970-FBB10F08-2871-4370-BF98-3A63F4E0D4F4Q58564259-234CAA74-1E9F-4F57-BAC9-E990445C6906Q64079563-CCFD8776-2136-4607-AFB6-24D687F00A87Q64113262-C0D96541-AAAE-42DF-8334-A8F589769F89Q90128704-32B95204-356C-4BB2-9B88-EB77EA9988E2Q91219377-EDAC48E2-80D2-4DAF-829B-6B946D19E6ECQ94567262-A08418FD-EE6A-4AC3-81EC-8BDDC4304EEC
P50
description
researcher
@en
wetenschapper
@nl
name
Jun-Nian Zheng
@en
Jun-Nian Zheng
@nl
type
label
Jun-Nian Zheng
@en
Jun-Nian Zheng
@nl
prefLabel
Jun-Nian Zheng
@en
Jun-Nian Zheng
@nl
P31
P496
0000-0003-0208-6410